Top News

Mar 19, 2018
By Pharmaceutical Technology Editors
The companies intend to jointly develop and commercialize Lenvima (lenvatinib mesylate) as a monotherapy and an in-combination therapy for treating multiple cancer types.
Mar 13, 2018
By Pharmaceutical Technology Editors
The $11.6-billion acquisition strengthens Sanofi's position in hematology and specialty medicines.
Mar 08, 2018
By Pharmaceutical Technology Editors
The new progesterone active pharmaceutical ingredient, used captively by Pfizer for the past four years, reduces carbon footprint by more than 70%.
Mar 06, 2018
By Pharmaceutical Technology Editors
The pharma major will spin out six molecules in early stage inflammation and autoimmune programs into a new company called Viela Bio.
Feb 28, 2018
By Pharmaceutical Technology Editors
A jury verdict requiring Gilead Sciences to pay $2.54 billion for patent infringement to competitor Merck & Co. over Gilead's Harvoni (ledipasvir and sofosbuvir) and Sovaldi (sofosbuvir), two best-selling hepatitis C drugs, has been overturned.
Feb 27, 2018
By Pharmaceutical Technology Editors
Roche will acquire oncology-focused healthcare technology and services company Flatiron Health for $1.9 billion to further its personalized oncological healthcare strategy.
Feb 13, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
A $800-million acquisition of MPI Research expands Charles River's offerings for early-stage contract research.
Feb 01, 2018
The President described US drug costs as unfair and stated that prices will come down.
Jan 30, 2018
By Pharmaceutical Technology Editors
The acquisition will strengthen Sanofi's R&D strategy and expands its franchise for rare blood disorders.
Jan 24, 2018
By Pharmaceutical Technology Editors
The acquisition would boost Sanofi's position in hematology and specialty medicines.
native1_300x100
lorem ipsum